Implications of the HFMA-GHX study of risk-based contracting
In this article discussing implications of the findings of a December 2020 HFMA study, sponsored by GHX, healthcare leaders share their perspectives on key factors contributing to their organizations' success under value-based contracts.
News briefs: The new COVID-19 relief legislation could result in a big Medicare payment cut
The $1.9 trillion American Rescue Plan, which was signed into law March 11, could lead to a significant reduction in Medicare revenues if Congress does not act.
Survey responses provide snapshot of the toll of the COVID-19 pandemic on hospital finances
A government-issued report used survey responses from hospital administrators to examine the impact of the COVID-19 pandemic on hospitals in various aspects, including finances.
3 questions with Katie Gilfillan: Why it’s time for the healthcare industry to address cost effectiveness of health
HFMA’s director of professional practice and clinical relationships discusses the importance of the Association’s Cost Effectiveness of Health event.
Congressional hearing showcases the divergence in the two parties’ views on how to improve U.S. healthcare
One witness at a hearing of a House subcommittee touted price transparency as an essential tool for addressing healthcare costs.
Health system leaders state their case for prolonging the moratorium on the Medicare payment sequester
Hospitals and health systems urgently need Congress to extend the freeze on the 2% Medicare payment sequester, industry leaders said.
Health system leaders share top approaches for success under value-based payment
Three health system executives discuss the key factors that have contributed to their organizations’ long-standing success with value-based payment models.
Healthcare News of Note: Hospitals await disbursement of remaining COVID-19 relief funds
Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles, including hospitals waiting on COVID-19 relief funds, HHS postponing implementation of the SUNSET rule and confirmation of a new HHS assistant secretary for health who is the first openly transgender person to be confirmed for a position by the Senate.
“Every one of us can make a change.” Dr. Zeev Neuwirth discusses how every stakeholder can improve the industry.
HFMA President and CEO Joe Fifer interviews Dr. Zeev Neuwirth about the dangers of fee-for-service and how every stakeholder has a responsibility to move the industry forward.
HHS delays implementation of rule requiring FQHCs to provide insulin, epinephrine at 340B prices
HHS has postponed a Trump administration regulation that would require federally qualified health centers to make certain drugs more affordable for low-income patients and will consider whether to withdraw the rule altogether.